Wellington Management Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$778K Sell
86,778
-4,570
-5% -$40.9K ﹤0.01% 1741
2025
Q1
$685K Buy
91,348
+2,291
+3% +$17.2K ﹤0.01% 1773
2024
Q4
$670K Sell
89,057
-18,763
-17% -$141K ﹤0.01% 1769
2024
Q3
$819K Buy
+107,820
New +$819K ﹤0.01% 1730
2020
Q1
Sell
-22,708
Closed -$78K 1915
2019
Q4
$78K Sell
22,708
-5,420
-19% -$18.6K ﹤0.01% 1997
2019
Q3
$80K Sell
28,128
-6,890
-20% -$19.6K ﹤0.01% 2008
2019
Q2
$133K Hold
35,018
﹤0.01% 2028
2019
Q1
$285K Buy
+35,018
New +$285K ﹤0.01% 1969
2017
Q2
Sell
-202,317
Closed -$1.7M 2161
2017
Q1
$1.7M Buy
+202,317
New +$1.7M ﹤0.01% 1774
2016
Q3
Sell
-256,120
Closed -$727K 2160
2016
Q2
$727K Sell
256,120
-1,240,739
-83% -$3.52M ﹤0.01% 1835
2016
Q1
$4.24M Sell
1,496,859
-5,973,580
-80% -$16.9M ﹤0.01% 1401
2015
Q4
$77.1M Sell
7,470,439
-31,497
-0.4% -$325K 0.02% 550
2015
Q3
$85.5M Buy
7,501,936
+520,365
+7% +$5.93M 0.02% 491
2015
Q2
$104M Sell
6,981,571
-38,712
-0.6% -$578K 0.03% 477
2015
Q1
$63.4M Sell
7,020,283
-368,990
-5% -$3.33M 0.02% 662
2014
Q4
$89.9M Buy
7,389,273
+1,529,847
+26% +$18.6M 0.02% 548
2014
Q3
$57.3M Buy
5,859,426
+510,081
+10% +$4.99M 0.02% 674
2014
Q2
$68.2M Buy
5,349,345
+1,329,584
+33% +$17M 0.02% 642
2014
Q1
$42.5M Sell
4,019,761
-771,469
-16% -$8.16M 0.01% 795
2013
Q4
$36.4M Buy
4,791,230
+2,159,640
+82% +$16.4M 0.01% 827
2013
Q3
$19.2M Buy
+2,631,590
New +$19.2M 0.01% 1014